The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.

Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according to a new study.

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.

One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these drugs is Ozempic,

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

The large study analyzed more 500,000 people with a history of opioid use disorder and more than 800,000 with alcohol use disorder. Results show that those who took Ozempic or a similar GLP-1 receptor agonist drug (which are approved to treat conditions such as type 2 diabetes or obesity) had a 40 percent lower chance of overdosing on opioids and a 50 percent lower risk of getting drunk compared to those who didn't take the medication.